Silarx Pharmaceutical, Inc.

FDA Regulatory Profile

Silarx Pharmaceutical, Inc. appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1416-2015, Class III) was initiated on August 21, 2015.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1416-2015Class IIILamivudine Oral Solution, USP, 10 mg per 1 mL, 240 mL bottle (8 ounces), Rx only, Manufactured by: SAugust 21, 2015